or Try an Advanced Search...

    Dystrophy Stocks List

    Symbol Grade Name % Change
    BLUE F bluebird bio, Inc. -1.68
    FULC F Fulcrum Therapeutics, Inc. -0.67
    IONS F Ionis Pharmaceuticals, Inc. -4.12
    SLDB F Solid Biosciences Inc. 5.44
    DYN F Dyne Therapeutics, Inc. -0.87
    SRPT F Sarepta Therapeutics, Inc. -0.32
    SMMT D Summit Therapeutics plc -1.07
    BNTC C Benitec Biopharma Limited -4.32
    WVE C WAVE Life Sciences Ltd. 0.63
    TRDA C Entrada Therapeutics, Inc. 0.67
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Muscular Dystrophy Duchenne Duchenne Muscular Dystrophy Biopharmaceutical Biotechnology Disease Genetic Genealogy Medical Genetics Medicine Rare Diseases Dystrophin Huntington's Disease Myotonic Dystrophy Antisense RNA Biology Cytoskeleton Disorders Drug Discovery Facioscapulohumeral Muscular Dystrophy Genetics

    Related ETFs - A few ETFs which own one or more of the above listed Dystrophy stocks.

    Symbol Grade Name Weight
    PINK D Simplify Health Care ETF 10.54
    MNTL D Tema Neuroscience and Mental Health ETF 5.71
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 4.85
    XBI D SPDR S&P Biotech ETF 4.47
    ARKG F ARK Genomic Revolution Multi-Sector ETF 3.85
    View all Dystrophy ETFs...
    Compare ETFs
    Compare BBC to ARKG Compare PINK to XBI Compare XBI to ARKG

        Dystrophy Stocks Recent News

        Date Stock Title
        Nov 21 IONS Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech Stocks in 2024?
        Nov 20 SMMT Summit Therapeutics (SMMT) Hurt Bronte Capital. Here’s Why
        Nov 20 IONS Ionis Pharmaceuticals, Inc. (IONS): Among the Best Genomics Stocks to Buy Right Now
        Nov 18 IONS Here's Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 Weeks
        Nov 16 BLUE bluebird bio Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        Nov 15 BLUE JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options
        Nov 15 SRPT Sarepta Therapeutics, Inc. (SRPT): Among 12 High Growth Large Cap Stocks to Buy Now
        Nov 15 BLUE bluebird bio extends selloff as BofA and J.P. Morgan cut after Q3 results
        Nov 15 WVE Wave Life Sciences to Present at Jefferies London Healthcare Conference
        Nov 15 WVE Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20
        Nov 15 FULC Fulcrum Therapeutics Third Quarter 2024 Earnings: US$0.35 loss per share (vs US$0.39 loss in 3Q 2023)
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Muscular Dystrophy Duchenne Duchenne Muscular Dystrophy Biopharmaceutical Biotechnology Disease Genetic Genealogy Medical Genetics Medicine Rare Diseases Dystrophin Huntington's Disease Myotonic Dystrophy Antisense RNA Biology Cytoskeleton Disorders Drug Discovery Facioscapulohumeral Muscular Dystrophy Genetics
        Dystrophy

        Dystrophy is the degeneration of tissue, due to disease or malnutrition, most likely due to heredity.

        More about Dystrophy
        Browse All Tags